Click here to sign in with or
Forget Password?
Learn more
share this!
1
7
Share
Email
August 15, 2022
by Toho University
A cytokine named TRAIL binds to TRAIL receptors and kills cancer cells, but not normal cells. Various anticancer drugs targeting TRAIL receptors have been developed and gained great attention as a promising cancer therapeutics, but a certain population of cancer patients does not respond to the therapy. Therefore, many researchers have tried to identify a key molecule that determines the sensitivity of cancer cells to the TRAIL therapy.
The surface of every cell in our body is decorated with sugar chains called glycans, which determine the character of cells and enable cells to talk to each other. Glycan structures on the cell surface dramatically change when cells become cancerous. In this multi-institutional study published in Oncogene and led by Associate Professor Moriwaki in Toho University and Professor Miyoshi in Osaka University, researchers identified the glycan structure that makes cancer cells vulnerable to the death-inducing cytokine known as TRAIL, and paved a new way to develop a predictive biomarker for the TRAIL therapy.
Previously, Drs. Moriwaki and Miyoshi had found that fucose, which is one of building blocks of glycans, is an important sugar affecting the sensitivity of cancer cells to TRAIL. This time, they closely looked at the structures of glycans carrying fucose and discovered that cancer cells highly expressing the specific glycan structure named Lewis glycans on the surface were more vulnerable to TRAIL-induced cell death. They also found that although Lewis glycans are attached to proteins and lipids on the surface, Lewis glycans on lipids, but not on proteins, enhance TRAIL sensitivity. Furthermore, they could predict the sensitivity of colon cancer patient-derived cancer cells to TRAIL-induced cell death by testing the expression level of Lewis glycans. Therefore, this specific glycan structure is expected to be a valuable biomarker to predict the effectiveness of the TRAIL therapy.
Dr. Tomoya Fukuoka, a lead author of the study, said, “These findings shed light on the regulatory mechanism of TRAIL-induced cell death and encourage the development of a novel therapeutic strategy targeting the TRAIL signaling. Furthermore, TRAIL resistance is a vital intrinsic mechanism that renders cancer cells insensitive to certain kind of cancer immunotherapy, so these findings also have a great impact on the development of a predictive biomarker for cancer immunotherapy.”
This research was conducted in collaboration with Drs. Keiichi Ozono at Osaka University, Masahiro Inoue at Kyoto University, Yasuhide Miyamoto at Osaka International Cancer Institute, and Hiroyuki Kaji at National Institute of Advanced Industrial Science and Technology.
Explore further
Facebook
Twitter
Email
Feedback to editors
Aug 19, 2022
0
Aug 18, 2022
0
Aug 18, 2022
1
Aug 17, 2022
0
Aug 17, 2022
0
3 hours ago
3 hours ago
9 hours ago
13 hours ago
Aug 19, 2022
Aug 19, 2022
Aug 19, 2022
Aug 03, 2022
Jul 13, 2022
Mar 24, 2020
Jan 28, 2022
Aug 03, 2021
Jan 26, 2018
9 hours ago
13 hours ago
Aug 19, 2022
Aug 19, 2022
Aug 19, 2022
Aug 19, 2022
Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use our contact form. For general feedback, use the public comments section below (please adhere to guidelines).
Please select the most appropriate category to facilitate processing of your request
Thank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.
Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient’s address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.
Get weekly and/or daily updates delivered to your inbox. You can unsubscribe at any time and we’ll never share your details to third parties.
More information Privacy policy
Daily science news on research developments and the latest scientific innovations
The latest engineering, electronics and technology advances
The most comprehensive sci-tech news coverage on the web
This site uses cookies to assist with navigation, analyse your use of our services, collect data for ads personalisation and provide content from third parties. By using our site, you acknowledge that you have read and understand our Privacy Policy and Terms of Use.